Clinical Trials
Clinical Trial of Ayurvedic Remedy For COVID-19 Shows Groundbreaking Results
A groundbreaking interim report on a clinical trial being conducted in three hospitals has shown that Covid-19 patients on natural treatment are resolving most symptoms earlier than those on conventional medicines.
The interim report on combination treatment of an Ayurvedic...
News
Indoco launches Fevindo 400 mg tablets for COVID-19
Indoco Remedies announced the launch of Fevindo (favipiravir) 400 mg tablets in India. Fevindo - 400 is an antiviral drug, effective against the RNA-based influenza virus. The drug has been approved by DCGI in the treatment of COVID-19.
Fevindo 400...
News
Sputnik V: World’s First COVID-19 Vaccine Now Available to Public in Russia
The first batch of Russia’s coronavirus vaccine Sputnik V has entered “civil circulation”, reports from state media claimed on Thursday. The first potential vaccine in the world is now available to public in the capital city of Moscow.
Although the...
News
Stevanato Group launches US Technology Center in Boston
Italian-based Stevanato Group, a leading producer of pharmaceutical glass containers and provider of integrated capabilities for drug delivery systems, has officially inaugurated its Technology Excellence Center (TEC) in Boston, Massachusetts.
The new Center provides a full-service approach to support biopharma...
News
Emma Stoddart appointed as new Chief Financial Officer at ChargePoint Technology
ChargePoint Technology, specialists in contained and sterile powder transfer solutions, has further strengthened its leadership team with the appointment of Emma Stoddart as Chief Financial Officer.
Having been a partner at Grant Thornton where she spent over 20 years of...
News
Durbin to Coordinate Global Early Access Program for New Medicine
Durbin, part of Uniphar Group, has been appointed to design and implement a global Early Access Program (EAP) on behalf of Jazz Pharmaceuticals plc for a new medicine containing the active substance, solriamfetol, and known commercially as Sunosi®.
The therapy...
News
PHARMASEAL’s £1million crowdfunding campaign aimed at increasing clinical trial turnaround times gains momentum
A £1 million crowdfunding campaign launched by PHARMASEAL to revolutionise global clinical trials and vaccine development has reached the next campaign milestone.
Launched by the new provider of clinical trial management and governance solutions last month, the campaign is aimed...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read